Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm


Journal

Journal of psychiatry & neuroscience : JPN
ISSN: 1488-2434
Titre abrégé: J Psychiatry Neurosci
Pays: Canada
ID NLM: 9107859

Informations de publication

Date de publication:
01 05 2019
Historique:
entrez: 27 2 2019
pubmed: 27 2 2019
medline: 10 6 2020
Statut: ppublish

Résumé

Major depression and anxiety are highly prevalent and involve chronic dysregulation of serotonin, but they remain poorly understood. Here, we review novel transcriptional (genetic, epigenetic) and posttranscriptional (microRNA, alternative splicing) mechanisms implicated in mental illness, focusing on a key serotonin-related regulator, the serotonin 1A (5-HT1A) receptor. Functional single-nucleotide polymorphisms and stress-induced DNA methylation of the 5-HT1A promoter converge to differentially alter pre- and postsynaptic 5-HT1A receptor expression associated with major depression and reduced therapeutic response to serotonergic antidepressants. Major depression is also associated with altered levels of splice factors and microRNA, posttranscriptional mechanisms that regulate RNA stability. The human 5-HT1A 3′-untranslated region is alternatively spliced, removing microRNA sites and increasing 5-HT1A expression, which is reduced in major depression and may be genotype-dependent. Thus, the 5-HT1A receptor gene illustrates the convergence of genetic, epigenetic and posttranscriptional mechanisms in gene expression, neurodevelopment and neuroplasticity, and major depression. Understanding gene regulatory mechanisms could enhance the detection, categorization and personalized treatment of major depression.

Identifiants

pubmed: 30807072
doi: 10.1503/jpn.180209
pmc: PMC6488484

Substances chimiques

MicroRNAs 0
Receptor, Serotonin, 5-HT1A 112692-38-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-176

Informations de copyright

© 2019 Joule Inc. or its licensors

Déclaration de conflit d'intérêts

P. Albert sits on the JPN editorial board. He was not involved in the decision-making on this manuscript. No other competing interests declared.

Références

Sci Rep. 2014 Nov 20;4:7049
pubmed: 25412229
Br J Psychiatry. 2011 Feb;198(2):129-35
pubmed: 21282783
Psychiatry Res Neuroimaging. 2017 Dec 30;270:1-7
pubmed: 28985530
Neuropsychobiology. 2011;64(1):1-8
pubmed: 21577007
Eur Neuropsychopharmacol. 2018 Apr;28(4):445-456
pubmed: 29174531
J Affect Disord. 2012 Dec 15;142(1-3):82-9
pubmed: 22868061
Mol Psychiatry. 2007 Jun;12(6):522-43
pubmed: 17160067
Neurobiol Dis. 2015 Oct;82:332-341
pubmed: 26188176
Curr Opin Neurobiol. 2013 Feb;23(1):133-42
pubmed: 22995550
Psychiatry Res. 2014 Dec 30;224(3):139-51
pubmed: 25456520
Eur Arch Psychiatry Clin Neurosci. 2010 Jun;260(4):317-26
pubmed: 19894072
Int J Neuropsychopharmacol. 2013 Apr;16(3):621-9
pubmed: 22564678
PLoS One. 2014 Sep 04;9(9):e106810
pubmed: 25188405
Genes Brain Behav. 2018 Mar;17(3):e12446
pubmed: 29251832
JAMA. 2009 Jun 17;301(23):2462-71
pubmed: 19531786
Am J Geriatr Psychiatry. 2014 Oct;22(10):971-9
pubmed: 24021217
Curr Opin Psychiatry. 2018 Jan;31(1):7-16
pubmed: 29076893
Mol Pharmacol. 2010 Feb;77(2):126-35
pubmed: 19917878
Science. 1996 Nov 29;274(5292):1527-31
pubmed: 8929413
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
J Biol Chem. 2012 Feb 24;287(9):6615-27
pubmed: 22232550
CNS Drugs. 2009 Aug;23(8):627-47
pubmed: 19594193
Transl Psychiatry. 2012 Jan 10;2:e66
pubmed: 22832728
J Hum Genet. 2009 Nov;54(11):629-33
pubmed: 19730445
Biol Psychiatry. 2007 Sep 15;62(6):600-6
pubmed: 17481593
Eur J Neurosci. 2011 Jan;33(1):49-57
pubmed: 21156002
Mol Psychiatry. 1996 Dec;1(6):453-60
pubmed: 9154246
J Neurosci. 2004 Jun 9;24(23):5420-6
pubmed: 15190115
Prog Neurobiol. 2009 May;88(1):17-31
pubmed: 19428959
Psychiatry Res. 2011 Jan 30;185(1-2):20-6
pubmed: 20594600
CNS Spectr. 2016 Oct;21(5):379-384
pubmed: 26780922
Neuromolecular Med. 2004;5(1):27-40
pubmed: 15001810
Nat Neurosci. 2006 Nov;9(11):1362-3
pubmed: 17013380
Am J Psychiatry. 2010 May;167(5):509-27
pubmed: 20231323
Neuroimage. 2014 Jul 1;94:33-39
pubmed: 24607934
Neuropharmacology. 2008 Nov;55(6):977-85
pubmed: 18639564
J Neurosci. 2017 Dec 6;37(49):11967-11978
pubmed: 29101244
Eur Neuropsychopharmacol. 2015 Nov;25(11):2036-48
pubmed: 26433268
Biol Psychiatry. 2016 Jan 15;79(2):87-96
pubmed: 25687413
Front Cell Neurosci. 2017 May 23;11:139
pubmed: 28588453
J Affect Disord. 2011 Aug;132(3):450-3
pubmed: 21453976
Neuropharmacology. 2003 Jan;44(1):93-101
pubmed: 12559126
Nature. 2008 Oct 16;455(7215):894-902
pubmed: 18923511
Psychiatr Genet. 1999 Jun;9(2):105-6
pubmed: 10412191
Int J Neuropsychopharmacol. 2006 Jun;9(3):349-55
pubmed: 16316476
Mol Brain. 2016 Aug 03;9(1):77
pubmed: 27488351
Nat Neurosci. 2005 Jun;8(6):828-34
pubmed: 15880108
Arch Gen Psychiatry. 2000 Aug;57(8):729-38
pubmed: 10920459
Psychoneuroendocrinology. 2014 Dec;50:274-9
pubmed: 25247748
J Neurosci. 2019 Feb 20;39(8):1334-1346
pubmed: 30552180
Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):115-23
pubmed: 18484082
Eur Arch Psychiatry Clin Neurosci. 2013 Mar;263(2):105-18
pubmed: 22752684
Sci Rep. 2018 Apr 10;8(1):5788
pubmed: 29636529
JAMA. 2007 Apr 18;297(15):1683-96
pubmed: 17440145
Neurosci Lett. 2010 Nov 12;485(1):11-5
pubmed: 20817074
Science. 2002 Jul 19;297(5580):400-3
pubmed: 12130784
Behav Brain Funct. 2006 Apr 20;2:14
pubmed: 16626484
J Sport Exerc Psychol. 2015 Dec;37(6):637-45
pubmed: 26866771
Psychiatr Genet. 2010 Feb;20(1):8-13
pubmed: 19997044
Psychiatry Investig. 2013 Dec;10(4):399-406
pubmed: 24474990
Front Behav Neurosci. 2014 Jun 06;8:199
pubmed: 24936175
J Neurosci. 2018 Sep 19;38(38):8200-8210
pubmed: 30093565
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Biol Psychiatry. 2009 Sep 1;66(5):477-85
pubmed: 19500776
Arch Gen Psychiatry. 2009 Jan;66(1):33-40
pubmed: 19124686
Science. 2003 Jul 18;301(5631):386-9
pubmed: 12869766
J Neurosci. 2003 Aug 13;23(19):7415-25
pubmed: 12917378
Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):749-55
pubmed: 26408209
J Neurosci. 1993 Dec;13(12):5164-71
pubmed: 8254366
J Neurosci. 1998 Sep 15;18(18):7394-401
pubmed: 9736659
Mol Psychiatry. 2016 Mar;21(3):328-38
pubmed: 26100539
J Psychiatr Res. 2014 Jun;53:47-53
pubmed: 24657235
Eur Neuropsychopharmacol. 2018 Apr;28(4):457-482
pubmed: 29525411
Science. 2010 Sep 17;329(5998):1537-41
pubmed: 20847275
Nature. 2018 Mar 29;555(7698):678-682
pubmed: 29562234
Arch Gen Psychiatry. 2011 May;68(5):444-54
pubmed: 21199959
Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120004
pubmed: 23440462
Sci Rep. 2017 Oct 2;7(1):12536
pubmed: 28970569
Mol Psychiatry. 2012 Jun;17(6):612-23
pubmed: 21808255
Acta Neuropsychiatr. 2015 Dec;27(6):353-61
pubmed: 25990886
Ther Adv Drug Saf. 2018 Jul;9(7):355-366
pubmed: 30034777
Neuron. 2007 Nov 8;56(3):422-37
pubmed: 17988628
Wiley Interdiscip Rev Dev Biol. 2018 Jan;7(1):
pubmed: 28837264
Sci Rep. 2016 Jul 12;6:29551
pubmed: 27404655
Psychiatry Investig. 2017 Jan;14(1):86-92
pubmed: 28096880
Transl Psychiatry. 2017 Jun 13;7(6):e1150
pubmed: 28608854
J Biol Chem. 1990 Apr 5;265(10):5825-32
pubmed: 2156831
J Affect Disord. 2018 Nov;240:146-154
pubmed: 30071418
ACS Chem Neurosci. 2019 Jul 17;10(7):3197-3206
pubmed: 30694044
PLoS One. 2012;7(9):e45813
pubmed: 23029256
Int J Neuropsychopharmacol. 2016 Apr 20;19(4):
pubmed: 26721949
Wiley Interdiscip Rev RNA. 2017 Mar;8(2):
pubmed: 27748060
Mol Psychiatry. 2018 Jan;23(1):133-142
pubmed: 28373689
Nat Neurosci. 2007 Sep;10(9):1103-9
pubmed: 17726476
Nat Med. 2016 Mar;22(3):238-49
pubmed: 26937618
J Neurosci. 2004 Jan 21;24(3):589-91
pubmed: 14736842
Nat Med. 2013 Jun;19(6):680-1
pubmed: 23744149
J Psychiatry Neurosci. 2011 Nov;36(6):363-5
pubmed: 22011561
Biol Psychiatry. 2008 Sep 15;64(6):498-504
pubmed: 18486105
J Neurochem. 1996 Jun;66(6):2621-4
pubmed: 8632190
Int J Psychophysiol. 2015 Dec;98(3 Pt 2):506-14
pubmed: 25448266
Acta Psychiatr Scand. 2018 Mar;137(3):263-272
pubmed: 29363117
Brain Res. 2013 Mar 7;1499:136-44
pubmed: 23333373
Cell Rep. 2017 Jan 31;18(5):1144-1156
pubmed: 28147271
Physiol Rev. 1992 Jan;72(1):165-229
pubmed: 1731370
Pain. 2013 Mar;154(3):377-84
pubmed: 23318131
J Pharmacol Sci. 2014;125(4):347-54
pubmed: 25048113
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2378-81
pubmed: 22826338
Neuropsychopharmacology. 2014 Jan;39(2):291-302
pubmed: 23907404
J Neurosci. 2011 Apr 20;31(16):6008-18
pubmed: 21508226
Neurosci Biobehav Rev. 2014 Jan;38:173-92
pubmed: 24300695
J Affect Disord. 2016 Feb;191:123-31
pubmed: 26655122
Mol Psychiatry. 2010 Aug;15(8):831-43
pubmed: 19381154
Psychiatry Clin Neurosci. 2012 Jun;66(4):337-43
pubmed: 22624739
Nature. 1987 Sep 3-9;329(6134):75-9
pubmed: 3041227
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2426-43
pubmed: 22826343
J Affect Disord. 2011 Dec;135(1-3):56-65
pubmed: 21439648
Mol Neurobiol. 2017 Dec;54(10):8263-8277
pubmed: 27914010
Wiley Interdiscip Rev Dev Biol. 2018 Jan;7(1):
pubmed: 29072810
Science. 2006 Oct 6;314(5796):140-3
pubmed: 17023662
Nature. 2018 Jul;559(7712):98-102
pubmed: 29950730
Life Sci. 2003 Feb 28;72(15):1665-82
pubmed: 12559389
Am J Psychiatry. 2006 Sep;163(9):1588-93
pubmed: 16946185
J Psychiatr Res. 2013 Sep;47(9):1222-7
pubmed: 23702251
Mol Psychiatry. 2017 May;22(5):760-773
pubmed: 27528462
J Neural Transm (Vienna). 2007;114(8):1065-8
pubmed: 17401528
Curr Opin Cell Biol. 2017 Apr;45:8-16
pubmed: 28129587
Biol Psychiatry. 2015 Oct 15;78(8):563-571
pubmed: 24882568
Front Cell Neurosci. 2017 Jul 14;11:202
pubmed: 28769763
Eur Neuropsychopharmacol. 2011 Jan;21(1):129-39
pubmed: 20638825
Neuropharmacology. 2010 Feb;58(2):452-6
pubmed: 19747927
J Psychopharmacol. 2000 Jun;14(2):177-85
pubmed: 10890313
Psychopharmacology (Berl). 2013 Jan;225(1):61-74
pubmed: 22820867
Mol Pharmacol. 2012 Feb;81(2):106-12
pubmed: 22031471
Depress Anxiety. 2011 Jul;28(7):568-73
pubmed: 21449006
Am J Psychiatry. 2006 Jan;163(1):28-40
pubmed: 16390886
Nat Neurosci. 2004 Aug;7(8):847-54
pubmed: 15220929
Front Neurosci. 2010 Jun 17;4:35
pubmed: 20661455
Transl Psychiatry. 2019 Jan 16;9(1):5
pubmed: 30664620
J Neural Transm (Vienna). 2010 Jun;117(6):773-9
pubmed: 20454985
Transl Psychiatry. 2015 May 05;5:e563
pubmed: 25942044
Int J Neuropsychopharmacol. 2014 Apr;17(4):645-9
pubmed: 24331356
J Affect Disord. 2011 Jul;132(1-2):297-300
pubmed: 21397953
Genes Brain Behav. 2007 Oct;6(7):672-6
pubmed: 17284168
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 1):2375-97
pubmed: 23886513
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2619-24
pubmed: 22308408
Neuropharmacology. 2014 May;80:45-52
pubmed: 24418103
Sci Rep. 2018 Mar 2;8(1):3946
pubmed: 29500446
Hum Brain Mapp. 2018 Feb;39(2):1043-1055
pubmed: 29323797
J Affect Disord. 2018 Mar 1;228:222-228
pubmed: 29275155
J Affect Disord. 2009 Apr;114(1-3):224-31
pubmed: 18848359
Psychiatry Res Neuroimaging. 2018 Jun 30;276:15-23
pubmed: 29702461
Biol Psychiatry. 2010 Sep 15;68(6):536-43
pubmed: 20615496
Int J Neuropsychopharmacol. 2016 Apr 29;19(5):
pubmed: 26568455
Trends Pharmacol Sci. 2008 Sep;29(9):433-6
pubmed: 18585794
Nat Neurosci. 2015 Nov;18(11):1606-16
pubmed: 26389840
Transl Psychiatry. 2014 Dec 16;4:e490
pubmed: 25514753
Sci Rep. 2016 Nov 29;6:38048
pubmed: 27897266
Pediatrics. 2010 May;125(5):876-88
pubmed: 20385637
Neurosci Biobehav Rev. 2017 Jun;77:317-326
pubmed: 28342763
Mol Psychiatry. 2007 Mar;12(3):247-57
pubmed: 17146470
J Psychiatr Res. 2013 Nov;47(11):1665-72
pubmed: 23911056
Nature. 2002 Mar 28;416(6879):396-400
pubmed: 11919622
PLoS One. 2012;7(8):e43221
pubmed: 22952650
Neuropsychobiology. 2013;67(4):192-200
pubmed: 23635830
Brain Struct Funct. 2018 Jul;223(6):2609-2625
pubmed: 29550938
Front Hum Neurosci. 2013 Oct 31;7:704
pubmed: 24198772
Nat Neurosci. 2006 Apr;9(4):519-25
pubmed: 16501568
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2402-15
pubmed: 22826341
Eur Arch Psychiatry Clin Neurosci. 2014 Dec;264(8):729-39
pubmed: 24158751
Neuropsychopharmacology. 2009 Sep;34(10):2275-84
pubmed: 19458612
Int Clin Psychopharmacol. 2016 Jan;31(1):1-7
pubmed: 26544898
J Clin Psychiatry. 2000;61 Suppl 6:7-11
pubmed: 10775018
Neurosci Biobehav Rev. 2018 Jan;84:272-288
pubmed: 28859997
Neuropsychopharmacology. 2015 Jun;40(7):1692-9
pubmed: 25578798
Annu Rev Pharmacol Toxicol. 2013;53:59-87
pubmed: 23020296
J Affect Disord. 2015 Sep 01;183:90-7
pubmed: 26001668
PLoS One. 2014 Dec 22;9(12):e115908
pubmed: 25531106
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):15755-60
pubmed: 26647181
J Neurochem. 2004 Feb;88(4):857-68
pubmed: 14756806
Neurotherapeutics. 2018 Jan;15(1):200-215
pubmed: 29204954
Nature. 2015 Jul 30;523(7562):588-91
pubmed: 26176920
Neuron. 2010 Jan 14;65(1):40-52
pubmed: 20152112
J Neurosci. 2006 Feb 8;26(6):1864-71
pubmed: 16467535
Neuropsychopharmacology. 2011 Feb;36(3):638-51
pubmed: 21048700
Curr Drug Targets. 2013 May 1;14(5):531-48
pubmed: 23547754
Genes Brain Behav. 2013 Feb;12(1):133-9
pubmed: 23036158
Neuron. 2014 Jul 16;83(2):344-360
pubmed: 24952960
J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):24S-35S
pubmed: 3323264
Transl Psychiatry. 2016 Mar 01;6:e746
pubmed: 26926882
J Psychiatry Neurosci. 2015 Jan;40(1):5-18
pubmed: 25285876
Int J Neuropsychopharmacol. 2018 Apr 1;21(4):371-381
pubmed: 29309585
Neuron. 2017 May 3;94(3):534-549.e9
pubmed: 28472655
Nature. 2011 Oct 26;478(7370):519-23
pubmed: 22031444
Lupus. 2011 Jun;20(7):678-89
pubmed: 21382916
Curr Opin Pharmacol. 2011 Feb;11(1):45-51
pubmed: 21377932
World J Biol Psychiatry. 2017 Feb;18(1):5-28
pubmed: 27603714
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2495-510
pubmed: 22826348

Auteurs

Paul R. Albert (PR)

From the Department of Neuroscience, Ottawa Hospital Research Institute, UOttawa Brain and Mind Research Institute, Ottawa, Ont., Canada.

Brice Le François (B)

From the Department of Neuroscience, Ottawa Hospital Research Institute, UOttawa Brain and Mind Research Institute, Ottawa, Ont., Canada.

Faranak Vahid-Ansari (F)

From the Department of Neuroscience, Ottawa Hospital Research Institute, UOttawa Brain and Mind Research Institute, Ottawa, Ont., Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH